STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits.

Chung SS, Giehl N, Wu Y, Vadgama JV. STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits. Int J Oncol. 2014 Feb; 44(2):403-11.

View in: PubMed

subject areas

Animals
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Blotting, Western
Breast Neoplasms
Cell Movement
Cell Proliferation
Cyclic S-Oxides
Drug Resistance, Neoplasm
Drug Synergism
Female
Humans
Immunoprecipitation
Mice
Neoplastic Stem Cells
NIH 3T3 Cells
Phosphorylation
Receptor, erbB-2
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
RNA, Small Interfering
Signal Transduction
STAT3 Transcription Factor
Tissue Array Analysis
Tumor Cells, Cultured

authors with profiles

Jaydutt V Vadgama, PhD
Yanyuan Wu, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support